Partnerships Update: November 2022

Partnerships Update: November 2022

Introducing our new Senior Partnerships Manager, Lucy Murphy 

Lucy has over 10 years’ experience in partnership development across medical education, social policy, and public health. Most recently, she was a Development Manager at WLZ, a social impact bond-funded early intervention program for children and young people addressing the attainment gap for disadvantaged youth struggling with their social, emotional, and academic wellbeing, targeting communities of high deprivation in London. 

Prior to this, Lucy was at the Royal College of Physicians (RCP), working to align cross-specialty CME, delivered on-site and through their online medical education hub, for clinicians of all career stages. Before RCP, she spent 4 years with the National Cancer Research Institute (NCRI) developing the commercial offering through sponsorship opportunities at the annual congress, and before this, Lucy was the Sponsorship Manager at the Royal Society of Medicine (RSM) for 6 years working across 59 medical specialty sections to identify opportunities and secure funding of academic events for healthcare professionals. 

Lucy is looking forward to joining the brilliant SES team as a Senior Partnerships Manager to support industry engagement across the independent medical education hubs and patient networks through development of strong relationships. 

CME symposia update 

Multiple Myeloma Hub: Holistic pain management in multiple myeloma 

On November 10, 2022, the Multiple Myeloma Hub hosted an EBAC accredited symposium on holistic pain management in multiple myeloma, which was worth 1 CME credit for live attendees. Chair Professor Mohamad Mohty was joined by expert speakers Professor Heinz Ludwig (Wilhelminen Cancer Research Institute, Vienna, AT), Dr Barry Quinn (Queens University Belfast, Belfast, IE), and Professor Flaminia Coluzzi (Sapienza University of Rome, Rome, IT). 

The speakers covered a range of topics, with Professor Heinz sharing insight on the presentation and management of pain in early stages of multiple myeloma, the importance of patient-reported outcomes to assist HCPs with accurately assessing pain, and an individualized holistic pain management plan. Dr Quinn spoke on the implementation of a holistic pain treatment plan in advanced disease, including barriers to pain assessment and communication, patient perspectives such as hidden pain, and how to overcome barriers to holistic pain assessment. Finally, Professor Coluzzi delivered a detailed and practical session on “dos” and “don’ts” in pain management, exploring challenging elements of pain management, such as prescribing with comorbidities (e.g., hepatic impairment), the use of rapid-acting opioids, and managing opioid side effects. 

Videos from the symposium will soon be added to the Multiple Myeloma Hub as enduring content, with updates shared via the hub’s social channels and homepage. 

GvHD Hub: The role of ECP in the management of GvHD 

On November 29, 2022, the GvHD Hub hosted a further EBAC accredited symposium on the role of extracorporeal photopheresis (ECP) in the management of graft-versus-host disease (GvHD), which was worth 2 CME credits for live attendees and was also chaired by Professor Mohamad Mohty. The symposium provided an opportunity for participants to interact with a world-renowned faculty and hear expert recommendations on treating patients with GvHD using ECP. 

Sessions from key opinion leaders, Professor Hildegard Greinix and Professor Daniel Wolff, explored patient selection, best practice recommendations, and combination treatments with ECP. The panel also led an interactive case-based discussion around the key considerations for the use of ECP plus steroids in GvHD. 

Video content from the symposium will soon be added to the GvHD Hub as enduring content, with updates also shared via the hub’s social channels and homepage. 

SES at the 64th ASH Annual Meeting and Exposition 

The SES team will be in New Orleans for the 64th American Society of Hematology (ASH) Annual Meeting and Exposition on December 10–13, 2022. 

We look forward to connecting with our industry partners and contacts and providing some fantastic updates from all of SES’ hematology platforms, particularly regarding the latest 2022 engagement statistics. 

Visit us at Booth 301 to learn about how we are driving quality open access, science-driven disease education through multichannel communications.  

Please also contact the partnerships team at should you wish to meet with the team at this event. 

Supporter update  

AML Hub 

The AML Hub welcomes a new supporter, Astellas, who will be supporting the platform at a contributor level. Astellas is a well-valued addition to the strong supporter base of the AML Hub.

The AML Hub also thanks BMS for renewing their support as a bronze supporter. BMS are a key contributor to the AML treatment pathway and we are delighted to see their reaffirmation of support for the AML Hub. 

Multiple Myeloma Hub 

BMS will be continuing to support the Multiple Myeloma Hub as a silver level supporter, which is a resounding show of support to our commitment to medical education in multiple myeloma. As a critical industry stakeholder in multiple myeloma, we are pleased to further develop our partnership with the BMS team.